| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 654677 | 67925 | CETRAXAL OTICO 3 MG/ML GOTAS OTICAS EN SOLUCION EN ENVASE UNIDOSIS | CETRAXAL OTICO 3 MG/ML GOTAS OTICAS EN SOLUCION EN ENVASE UNIDOSIS, 20 envases unidosis de 0,4 ml | 3 mg/ml | 45 | 20 | 51 | 20 envases unidosis de 0,4 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67925/67925_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67925/67925_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2513 | LABORATORIOS SALVAT S.A. | 2006-07-05 | 1 | 1 | 1 | 2006-07-05 | 2006-07-05 | 1 | 2011-07-04 | View Edit Delete | ||||||||||||
| 654791 | 34348 | BENADON 300 mg SOLUCION INYECTABLE | BENADON 300 mg SOLUCION INYECTABLE , 6 ampollas de 2 ml | 300 mg | 45 | 6 | 1 | 6 ampollas de 2 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/34348/34348_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/34348/34348_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2896 | TEOFARMA S.R.L. | 1960-09-01 | 1 | 1 | 1 | 1960-09-01 | 2013-06-10 | 1 | 2014-01-02 | 779207, 650105, 656767 | View Edit Delete | |||||||||||
| 655996 | 68016 | BARNASCAN 3000 MBq/ml SOLUCION INYECTABLE | BARNASCAN 3000 MBq/ml SOLUCION INYECTABLE , 1 vial de 10 ml | 3.000 Mbq/ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68016/68016_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68016/68016_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 40699 | ADVANCED ACCELERATOR APPLICATIONS MOLECULAR IMAGING IBERICA, S.L.U. | 2006-09-05 | 1 | 1 | 1 | 2006-09-05 | 2006-09-05 | 1 | 2011-10-10 | View Edit Delete | ||||||||||||
| 656168 | 04276036 | ABILIFY 7,5 MG/ML SOLUCION INYECTABLE | ABILIFY 7,5 MG/ML SOLUCION INYECTABLE, 1 vial de 1,3 ml | 7,5 mg/ml inyectable 1,3 ml | 45 | 1 | 34 | 1 vial de 1,3 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/04276036/04276036_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/04276036/04276036_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29813 | OTSUKA PHARMACEUTICAL S.A. | 2006-10-13 | 1 | 1 | 1 | 2006-10-13 | 2006-10-13 | 1 | 2011-10-17 | View Edit Delete | ||||||||||||
| 657445 | 00152005 | INFANRIX HEXA POLVO Y SUSPENSION PARA SUSPENSION INYECTABLE | INFANRIX HEXA POLVO Y SUSPENSION PARA SUSPENSION INYECTABLE, 1 vial + 1 jeringa precargada de disolvente | N/A (vacuna) | 45 | 1 | 34 | 1 vial + 1 jeringa precargada de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/00152005/00152005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/00152005/00152005_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2689 | GLAXOSMITHKLINE S.A. | 2001-03-21 | 1 | 1 | 1 | 2001-03-21 | 2001-03-21 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 657452 | 00152006 | INFANRIX HEXA POLVO Y SUSPENSION PARA SUSPENSION INYECTABLE | INFANRIX HEXA POLVO Y SUSPENSION PARA SUSPENSION INYECTABLE, 10 viales + 10 jeringas precargadas de disolvente | N/A (vacuna) | 45 | 10 | 34 | 10 viales + 10 jeringas precargadas de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/00152006/00152006_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/00152006/00152006_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2689 | GLAXOSMITHKLINE S.A. | 2001-03-21 | 1 | 1 | 1 | 2001-03-21 | 2001-03-21 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 656036 | 06346001 | TYSABRI 300 mg CONCENTRADO PARA SOLUCION PARA PERFUSION | TYSABRI 300 mg CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 15 ml | 300 mg | 45 | 1 | 34 | 1 vial de 15 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/06346001/06346001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06346001/06346001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 30027 | BIOGEN SPAIN S.L. | 2006-09-26 | 1 | 1 | 1 | 2006-09-26 | 2006-09-26 | 1 | 2012-01-09 | View Edit Delete | ||||||||||||
| 656088 | 04302001 | PRIALT 100 MICROGRAMOS/ML SOLUCION PARA PERFUSION | PRIALT 100 MICROGRAMOS/ML SOLUCION PARA PERFUSION, 1 vial de 1 ml | 100 microgramos/ml inyectable 1 ml | 45 | 1 | 34 | 1 vial de 1 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/04302001/04302001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/04302001/04302001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 38557 | ESTEVE PHARMACEUTICALS S.A. | 2006-10-17 | 1 | 1 | 1 | 2006-10-17 | 2006-10-17 | 1 | 2011-07-20 | View Edit Delete | ||||||||||||
| 656089 | 04302003 | PRIALT 100 MICROGRAMOS/ML SOLUCION PARA PERFUSION | PRIALT 100 MICROGRAMOS/ML SOLUCION PARA PERFUSION, 1 vial de 5 ml | 100 microgramos/ml inyectable 5 ml | 45 | 1 | 34 | 1 vial de 5 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/04302003/04302003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/04302003/04302003_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 38557 | ESTEVE PHARMACEUTICALS S.A. | 2006-10-17 | 1 | 1 | 1 | 2006-10-17 | 2006-10-17 | 1 | 2011-07-20 | View Edit Delete | ||||||||||||
| 656030 | 68033 | ACIDO VALPROICO ALTAN 400 mg POLVO PARA SOLUCION INYECTABLE EFG | ACIDO VALPROICO ALTAN 400 mg POLVO PARA SOLUCION INYECTABLE EFG, 1 vial | 400 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/68033/68033_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68033/68033_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 31805 | ALTAN PHARMACEUTICALS SA | 2006-09-18 | 1 | 1 | 1 | 2006-09-18 | 2006-09-18 | 0 | 2011-11-15 | View Edit Delete | ||||||||||||
| 658282 | 68354 | FOLINATO CALCICO ALTAN 350 mg POLVO PARA SOLUCION INYECTABLE EFG | FOLINATO CALCICO ALTAN 350 mg POLVO PARA SOLUCION INYECTABLE EFG , 1 vial | 350 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68354/68354_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68354/68354_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 31805 | ALTAN PHARMACEUTICALS SA | 2007-01-16 | 1 | 1 | 1 | 2007-01-16 | 2007-01-16 | 1 | 2011-11-15 | View Edit Delete | ||||||||||||
| 656807 | 61412 | GLYPRESSIN 1mg POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | GLYPRESSIN 1mg POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 5 viales + 5 ampollas de disolvente | 1 mg | 45 | 5 | 34 | 5 viales + 5 ampollas de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61412/61412_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61412/61412_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 31840 | FERRING S.A.U. | 1997-11-01 | 1 | 1 | 1 | 1997-11-01 | 2008-09-01 | 1 | 2011-06-28 | 673673 | View Edit Delete | |||||||||||
| 658306 | 06365001 | ELAPRASE 2 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | ELAPRASE 2 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 3 ml | 2 mg/ml inyectable 3 ml | 45 | 1 | 34 | 1 vial de 3 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/06365001/06365001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06365001/06365001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 42050 | TAKEDA FARMACEUTICA ESPANA S.A. | 2007-02-08 | 1 | 1 | 1 | 2007-02-08 | 2007-02-08 | 1 | 2012-01-09 | View Edit Delete | ||||||||||||
| 654820 | 48101 | GOBEMICINA 250 mg INYECTABLE | GOBEMICINA 250 mg INYECTABLE, 1 vial | 250 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 1969-06-01 | 1 | 1 | 1 | 1969-06-01 | 2013-08-08 | 0 | 2014-01-02 | 765438 | View Edit Delete | |||||||||||
| 654821 | 54341 | GOBEMICINA 1g INYECTABLE | GOBEMICINA 1g INYECTABLE, 1 vial | 1.000 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 1978-09-01 | 1 | 1 | 1 | 1978-09-01 | 2013-08-08 | 0 | 2014-01-02 | 882829 | View Edit Delete | |||||||||||
| 654823 | 48100 | GOBEMICINA 500 mg INYECTABLE | GOBEMICINA 500 mg INYECTABLE, 1 vial | 500 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 1969-06-01 | 1 | 1 | 1 | 1969-06-01 | 2013-08-08 | 0 | 2014-01-02 | 765446 | View Edit Delete | |||||||||||
| 656073 | 04285032 | APIDRA 100 UNIDADES/ML,SOLOSTAR SOLUCION INYECTABLE EN PLUMA PRECARGADA | APIDRA 100 UNIDADES/ML,SOLOSTAR SOLUCION INYECTABLE EN PLUMA PRECARGADA, 5 plumas precargadas de 3 ml | 100 U/ml | 66 | 5 | 49 | 5 plumas precargadas de 3 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/04285032/04285032_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/04285032/04285032_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 42153 | SANOFI AVENTIS S.A. | 2006-09-27 | 1 | 1 | 1 | 2006-09-27 | 2006-09-27 | 1 | 2011-10-14 | View Edit Delete | ||||||||||||
| 656920 | 61645 | CARBON ULTRA ADSORBENTE LAINCO 125 mg/ml GRANULADO PARA SUSPENSIÓN ORAL | CARBON ULTRA ADSORBENTE LAINCO 125 mg/ml GRANULADO PARA SUSPENSIÓN ORAL, 1 frasco de 200 ml | 125 mg/ml | 71 | 1 | 17 | 1 frasco de 200 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61645/61645_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61645/61645_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1614 | LAINCO S.A. | 1998-01-01 | 1 | 1 | 1 | 1998-01-01 | 2009-06-02 | 1 | 2011-05-27 | 655811 | View Edit Delete | |||||||||||
| 656921 | 61645 | CARBON ULTRA ADSORBENTE LAINCO 125 mg/ml GRANULADO PARA SUSPENSIÓN ORAL | CARBON ULTRA ADSORBENTE LAINCO 125 mg/ml GRANULADO PARA SUSPENSIÓN ORAL, 1 frasco de 400 ml | 125 mg/ml | 71 | 1 | 17 | 1 frasco de 400 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61645/61645_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61645/61645_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1614 | LAINCO S.A. | 1998-01-01 | 1 | 1 | 1 | 1998-01-01 | 2009-06-02 | 1 | 2011-05-27 | 669218 | View Edit Delete | |||||||||||
| 656346 | 68158 | CICLOCHEM 15 MG/G CHAMPU | CICLOCHEM 15 MG/G CHAMPU , 1 frasco de 100 ml | 15 mg/g | 71 | 100 | 26 | 1 frasco de 100 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68158/68158_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68158/68158_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 67780 | GALENICUM DERMA S.L.U. | 2006-11-14 | 1 | 1 | 1 | 2006-11-14 | 2006-11-14 | 1 | 2011-10-24 | View Edit Delete |
Page 134 of 1036, showing 20 records out of 20709 total, starting on record 2661, ending on 2680